The effects of aspirin on pro-inflammatory response in subjects with diabetes mellitus

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2003
INTERVENTION: 1. Aspirin 300 mg 2. Aspirin 75 mg 3. Placebo CONDITION: Nutritional, Metabolic, Endocrine: Diabetes ; Nutritional, Metabolic, Endocrine ; Diabetes PRIMARY OUTCOME: Change in IL‐6 release in response to aspirin. SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: Not provided at time of registration
Epistemonikos ID: 2dff9243dbf80076601efbe9cfb0b1afcf03df65
First added on: Aug 21, 2024